Kinetics of cholesterol reverse transport system

胆固醇反向转运系统的动力学

基本信息

  • 批准号:
    02044109
  • 负责人:
  • 金额:
    $ 6.08万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for international Scientific Research
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1992
  • 项目状态:
    已结题

项目摘要

The first step of cholesterol reverse transport from peripheral cells to liver is the efflux of cholesterol from the surface of cells by plasma lipoprotein. To clarify the mechanism of the step, we used rat peritoneal macrophage and lipid microemulsion with apolipoprotein A-I. Free cholesterol was released from macrophage when macrophage was incubated with microemulsion and apolipoprotein. Furthermore, cholesterol and phospholipid were released into the incubation medium when it was incubated with only free apolipoprotein. We found that the addition of free apolipoprotein to macrophage caused the formation of discoidal HDL-like particle. The same result was observed using fibroblast and smooth muscle cell but the extent of the efflux of cholesterol from smooth muscle cell was less than that from other cells, The HDL-like particle was quickly disappeared when incubated with lipid microemulsion. Therefore, we concluded that cholesterol efflux from cells to plasma lipoprotein occurred via … More discoidal HDL-like particle.Free cholesterol released from cells is esterified on the surface of HDL and redistributed into plasma lipoproteins. The transfer reaction of lipid between plasma lipoproteins is catalyzed by plasma lipid transfer protein(LTP). We have established the purification of LTP from human plasma. To estimate the accurate transfer rate by LTP, we applied the new method using lipid microemulsion containing fluorescence-labeled lipid (pyrene compound) to the measurement of the transfer rate. The coverage of lipid microemulsion with apolipoprotein was necessary for the lipid transfer by LTP. There was little difference between the transfer rate of cholesteryl ester and triglyceride, however, cholesteryl ester was selectively transferred between microemulsion by LTP when microemulsion contained both cholesteryl ester and triglyceride. The difference of the selectivity of cholesteryl ester over triglyceride was more than a hundred times. Therefore the net movement of cholesteryl ester seemed to occur only between HDL-LDL cholesteryl ester pool and VLDL because there was no net movement of cholesteryl ester between cholesteryl ester-rich particles. Less
胆固醇从外周细胞逆向转运到肝脏的第一步是通过血浆脂蛋白将胆固醇从细胞表面流出。为了阐明这一步骤的机制,我们使用了大鼠腹腔巨噬细胞和载脂蛋白A-I的脂质微乳。巨噬细胞与微乳和载脂蛋白共同孵育后释放出游离胆固醇。此外,胆固醇和磷脂释放到孵育培养基时,它只与游离载脂蛋白孵育。我们发现,在巨噬细胞中加入游离载脂蛋白可引起盘状HDL样颗粒的形成。成纤维细胞和平滑肌细胞也有相同的结果,但平滑肌细胞的胆固醇流出量小于其他细胞。因此,我们得出结论,胆固醇从细胞流出到血浆脂蛋白是通过 ...更多信息 从细胞释放的游离胆固醇在HDL表面酯化并重新分布到血浆脂蛋白中。血浆脂质转移蛋白(LTP)催化血浆脂蛋白之间的脂质转移反应。我们已经建立了从人血浆中纯化LTP的方法。为了通过LTP准确估计转移速率,我们将使用含有荧光标记脂质(芘化合物)的脂质微乳液的新方法应用于转移速率的测量。载脂蛋白对脂质微乳的覆盖是LTP转移脂质的必要条件。胆固醇酯和甘油三酯的转移速率差异不大,但当微乳中同时含有胆固醇酯和甘油三酯时,胆固醇酯通过LTP在微乳之间选择性转移。胆固醇酯与甘油三酯的选择性相差上百倍。因此,胆固醇酯的净移动似乎只发生在HDL-LDL胆固醇酯池和VLDL之间,因为富含胆固醇酯的颗粒之间没有胆固醇酯的净移动。少

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
山本 章: "動物硬化と遺伝素因" 循環器科. 31. 29-38 (1992)
Akira Yamamoto:“动物僵硬和遗传易感性”心脏病学系 31. 29-38 (1992)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Francis.G.A.: "Regulation of the uptake of high-density lipoprotein-originated cholesteryl ester by Hep G2 cells:role of low-density lipoprotein and plasma lipid transfer protein." Biochemica et biophysica Acta. 1084. 159-166 (1991)
Francis.G.A.:“Hep G2 细胞对高密度脂蛋白来源的胆固醇酯的摄取调节:低密度脂蛋白和血浆脂质转移蛋白的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
R. O. Ryan: "Human apolipoprotein A-I liberated from high-density lipoprotein without denaturation." Biochemistry. 31. 4509-4514 (1992)
R. O. Ryan:“人类载脂蛋白 A-I 从高密度脂蛋白中释放出来,没有变性。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Ohnishi: Tokyo Kagaku Dojin. New Biochemical Research Vol.9 Hormone II Non Peptide Hormone, 155-159 (1992)
T. Ohnishi:东京化学同人。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
TAKAGI,A.: "Molecular studies on primary lipoprotein lipase(LPL)deficiency one base deletion(G^<916>)in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript." J.Clin.Invest.89. 581-591 (1992)
TAKAGI,A.:“对初级脂蛋白脂肪酶 (LPL) 缺陷的分子研究,LPL 基因外显子 5 中的一个碱基缺失 (G^<916>) 导致由于 LPL mRNA 转录物的缺失而无法检测到 LPL 蛋白。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ICHIKAWA Yoshiyuki其他文献

ICHIKAWA Yoshiyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ICHIKAWA Yoshiyuki', 18)}}的其他基金

Physiological functions and molecular biological properties of various retinoic acid synthases
各种视黄酸合酶的生理功能和分子生物学特性
  • 批准号:
    09670133
  • 财政年份:
    1997
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reaction mechanism of cholesterol transport system
胆固醇转运系统的反应机制
  • 批准号:
    05044173
  • 财政年份:
    1993
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似国自然基金

Apolipoprotein L3介导铁死亡促进MSS型结直肠癌抗肿瘤免疫效应的机制研究
  • 批准号:
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
利用转基因小鼠模型分析猪apolipoprotein R对脂肪沉积的影响
  • 批准号:
    31072004
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目

相似海外基金

Investigating and targeting apolipoprotein E4 in Down syndrome-associated Alzheimer's disease
研究和靶向唐氏综合症相关阿尔茨海默病中的载脂蛋白 E4
  • 批准号:
    10658660
  • 财政年份:
    2023
  • 资助金额:
    $ 6.08万
  • 项目类别:
Targeting Blood-CNS-Barrier in ALS via Apolipoprotein A1
通过载脂蛋白 A1 靶向 ALS 中的血液中枢神经系统屏障
  • 批准号:
    10680237
  • 财政年份:
    2023
  • 资助金额:
    $ 6.08万
  • 项目类别:
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
  • 批准号:
    10658408
  • 财政年份:
    2023
  • 资助金额:
    $ 6.08万
  • 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
  • 批准号:
    10601779
  • 财政年份:
    2023
  • 资助金额:
    $ 6.08万
  • 项目类别:
Prize 202209PJT - The Bhagirath Singh Early Career Prize in Infection and Immunity: Apolipoprotein control of inflammatory signalling in the endocytic pathway of dendritic cells
奖 202209PJT - Bhagirath Singh 感染和免疫领域早期职业奖:载脂蛋白控制树突状细胞内吞途径中的炎症信号
  • 批准号:
    477690
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Operating Grants
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
  • 批准号:
    RGPIN-2018-06116
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
  • 批准号:
    22K06460
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
  • 批准号:
    10674878
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
OAB-14 as a Potential Treatment for Alzheimer’s Disease: Apolipoprotein E3 as a Potential Mechanism for Improvement of Cognitive Deficits
OAB-14 作为阿尔茨海默病的潜在治疗方法:载脂蛋白 E3 作为改善认知缺陷的潜在机制
  • 批准号:
    486163
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
    Studentship Programs
Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes
载脂蛋白 B100 脂蛋白的载脂蛋白 C3 负载与 1 型糖尿病患者的心血管疾病
  • 批准号:
    10546500
  • 财政年份:
    2022
  • 资助金额:
    $ 6.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了